Senior insider sale
Chief Operating Officer at RAPPORT THERAPEUTICS, INC. — senior position signals high conviction
$58.2K
2.01K shares
What this filing means
GAULT CHERYL plans to sell 2.01K shares of RAPPORT THERAPEUTICS, INC. valued at approximately $58.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/5/2026ACC: 0001193125-26-094361
Officer· Chief Operating Officer
Since Mar 2026
2.01K
Shares to sell
$58.2K
Approx. market value
2.01K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units vesting under a registered plan
Compensation
3/3/2026
2.01KTotal acquired2.01K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/3/2026 | Restricted Stock Units vesting under a registered plan Compensation | 2.01K | — |
| Total | 2.01K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.01K
Market value
$58.2K
3/5/2026
Total
Units
2.01K
Value
$58.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/5/2026 | 2.01K | $58.2K | NASDAQ | Planned |
| Total | 2.01K | $58.2K | ||